Pavelka, K. Et Al. 2017. Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access. RHEUMATOLOGY INTERNATIONAL , vol.37, no.9 , 1469-1479.

Pavelka, K., Akkoc, N., Al-Maini, M., Zerbini, C. A. F., Karateev, D. E., Nasonov, E. L., ... Rahman, M. U.(2017). Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access. RHEUMATOLOGY INTERNATIONAL , vol.37, no.9, 1469-1479.

Pavelka, Karel Et Al. "Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access," RHEUMATOLOGY INTERNATIONAL , vol.37, no.9, 1469-1479, 2017

Pavelka, Karel Et Al. "Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access." RHEUMATOLOGY INTERNATIONAL , vol.37, no.9, pp.1469-1479, 2017

Pavelka, K. Et Al. (2017) . "Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access." RHEUMATOLOGY INTERNATIONAL , vol.37, no.9, pp.1469-1479.

@article{article, author={Karel Pavelka Et Al. }, title={Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access}, journal={RHEUMATOLOGY INTERNATIONAL}, year=2017, pages={1469-1479} }